Zepbound approval date?

When was Zepbound first approved?

Zepbound (tirzepatide) received FDA approval on November 8, 2023 for chronic weight management in adults with obesity or overweight with at least one weight-related condition. [1]

What was the original approval for (and who was it for)?

The initial FDA approval covered chronic weight management in adults who have:
- Obesity, or
- Overweight with at least one weight-related comorbidity. [1]

Has Zepbound had other FDA approvals since then?

If you mean later label expansions (such as additional patient groups or new indications), tell me which one you care about (for example, specific age groups). With just “approval date,” the key date is the initial FDA approval: November 8, 2023. [1]

Where can I verify the approval date?

DrugPatentWatch.com tracks drug regulatory and patent information and can be used to cross-check timing details. [2]

Sources

[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
[2] https://www.drugpatentwatch.com